Abstract
The potential importance of neuroleptic activity measures in the management of schizophrenia warrants attention to the methods for assessing neuroleptic bioactivity and stability of neuroleptic bioactivity over time. We have carried out measurements of serum neuroleptic and prolactin concentrations in 18 schizophrenic patients treated with haloperidol or thioridazine for up to 1 year. Serum neuroleptic levels were measurd by a radioreceptor assay using porcine striatum. The lower limit of sensitivity of the assay was 0.6 ng haloperidol/ml, the intra- and interassay coefficients of variation 3 and 9%, respectively. A linear correlation was observed between haloperidol dose (5–30 mg/d) and serum neuroleptic activity (r=0.706, P<0.001) and a curvilinear relationship between thioridazine dose (50–600 mg/d) and serum neuroleptic activity in schizophrenic outpatients. There was a positive correlation between serum neuroleptic and prolactin concentrations for the patients taking haloperidol (r=0.620, P<0.001) or thioridazine (r=0.542, P<0.001). In patients taking a constant dose of haloperidol or thioridazine for up to 1 year serum neuroleptic activity remained stable, suggesting the absence of metabolic tolerance; the observation of a decrease of 38±16% (mean ± SD) in serum prolactin concentrations in patients treated with haloperidol but no prolactin decrease with thioridazine suggests that under certain neuroleptic treatment conditions a functional tolerance develops in the tuberoinfundibular dopamine system.
Similar content being viewed by others
References
Balant-Georgia AE, Eisele R, Balant L, Garrone G (1984) Plasma haloperidol levels and therapeutic response in acute mania and schizophrenia. Eur Arch Psychiatr Neurol Sci 234:1–4
Brown WA, Laughren TP (1981a) Low serum prolactin and early relapse following neuroleptic withdrawal. Am J Psychiatr 138:237–239
Brown WA, Laughren TP (1981b) Tolerance to the prolactin-elevating effect of neuroleptics. Psychiatr Res 5:317–322
Brown WA, Laughren TP, Chisholm E, Williams EB (1982) Low serum neuroleptic levels predict relapse in schizophrenic patients. Arch Gen Psychiatry 39:998–1000
Calil HM, Avery DH, Hollister LE, Creese I, Snyder SH (1979) Serum levels of neuroleptics measured by dopamine radio-receptor assay and some clinical observations. Psychiatr Res 1:39–44
Cohen BM (1984) The clinical utility of plasma neuroleptic levels. In: Stancer et al. (eds) Guidelines for the use of psychotropic drugs. Spectrum Publications, pp 245–260
Cooper TB, Simpson GM, Lie JH (1976) Thymoleptic and neuroleptic drug levels in psychiatry: current status. Int Rev Neurobiol 19:269–309
Creese IE, Snyder SH (1977) A simple and sensitive radioreceptor assay for antischizophrenic drugs in blood. Nature 270:180–182
Curry SH (1985) Commentary: the strategy and value of neuroleptic drug monitoring. J Clin Psychopharmacol 5:263–271
Goldman Z, Ebstein RP, Lerer B, Zohar J, Hermoni M, Belmaker RH (1981) Haloperidol blood levels during dosage reduction in chronic schizophrenic patients. Neuropsychobiology 7:281–284
Gruen PH, Sachar EJ, Altman N, Langer G, Tabrizi MA, Halpern FS (1978a) Relation of plasma prolactin to clinical response in schizophrenic patients. Arch Gen Psychiatry 35:1222–1227
Gruen PH, Sachar EF, Langer G, Altman N, Leifer M, Frantz A, Halpern FS (1978b) Prolactin responses to neuroleptics in normal and schizophrenic subjects. Arch Gen Psychiatry 35:108–116
Ko GN, Korpi ER, Linnoila M (1985) On the clinical relevance and methods of quantification of plasma concentrations of neuroleptics. J Clin Psychopharmacol 5:253–262
Korpi ER, Ko GN, Phelps BH, Wyatt RJ (1984) Possible interference by the reduced haloperidol metabolite with the radioimmunoassay and radioreceptor assay of blood haloperidol. J Clin Psychopharmacol 3:332–335
Krska J, Sampath G, Shah A, Soni SD (1986) Radioreceptor assay of serum neuroleptic levels in psychiatric patients. Br J Psychiatry 148:187–193
Lader SR (1980) A radioreceptor assay for neuroleptic drugs in plasma. J Immunoassay 1:57–75
Linnoila M, Rosenblatt JE, Jeste D, Skinner T, Potter WZ, Wyatt RJ (1982) Disparate serum thioridazine concentration: liquid chromatography versus radioreceptor assay. J Pharmacol Toxicol 50:25–29
Meltzer HY, Fang VS (1976) The effect of neuroleptics on serum prolactin in schizophrenic patients. Arch Gen Psychiatry 33:279–286
Meltzer HY, Kaue IM, Kolakowska T (1983) Plasma levels of neuroleptics, prolactin levels and clinical response. In: Coyle JT, Enna SJ (eds) Neuroleptics: neurochemical, behavioral and clinical perspectives. Raven, New York, pp 255–279
Rao ML (1986) Modification of the radioreceptor assay technique for estimation of serum neuroleptic drug levels leads to improved precision and sensitivity. Psychopharmacology 90:548–553
Rao VAR, Bishop M, Coppen A (1980) Clinical state, plasma levels of haloperidol and prolactin: a correlation study in chronic schizophrenia. Br J Psychiatry 137:518–521
Ravichandran GK, Lu R-B, Shvartsburd A, Misra CH, Ho BT, Kahn M, Smith RC (1983) Prolactin response to single and multiple doses of haloperidol in schizophrenic patients. Psychiatr Res 11:61–69
Rimon R, Averbuch I, Rozick P, Fijman-Dainlovich L, Kara T, Dasberg H, Ebstein RP, Belmaker RH (1981) Serum and CSF levels of haloperidol by radioimmunoassay and radioreceptor assay during high-dose therapy of resistant schizophrenic patients. Psychopharmacology 73:197–199
Rubin RT, Hays SE (1980) The prolactin secretory response to neuroleptic drugs: mechanisms, applications and limitations. Psychoneuroendocrinology 5:121–137
Shvartsburd A, Sajadi C, Morton V, Mirabi M, Gordon J, Smith RC (1984) Blood levels of haloperidol and thioridazine during maintenance neuroleptic treatment of schizophrenic outpatients. J Clin Psychopharmacol 4:194–198
Tune LE, Creese I, DePaulo JR, Slavney PR, Coyle JT, Snyder SH (1980) Clinical state and serum neuroleptic levels measured by radioreceptor assay in schizophrenia. Am J Psychiatr 137:187–190
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rao, M.L., Brown, W.A. Stability of serum neuroleptic and prolactin concentrations during short- and long-term treatment of schizophrenic patients. Psychopharmacology 93, 237–242 (1987). https://doi.org/10.1007/BF00179941
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00179941